Mirae Asset Global Investments’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,167
| Closed | -$4.38K | – | 1605 |
|
|
2024
Q3 | $4.38K | Buy |
4,167
+742
| +22% | +$779 | ﹤0.01% | 1523 |
|
|
2024
Q2 | $5.82K | Sell |
3,425
-41,723
| -92% | -$70.9K | ﹤0.01% | 1488 |
|
|
2024
Q1 | $277K | Buy |
+45,148
| New | +$277K | ﹤0.01% | 2142 |
|
|
2023
Q4 | – | Sell |
-72,241
| Closed | -$270K | – | 2539 |
|
|
2023
Q3 | $270K | Buy |
72,241
+28,272
| +64% | +$106K | ﹤0.01% | 2177 |
|
|
2023
Q2 | $188K | Sell |
43,969
-14,966
| -25% | -$63.9K | ﹤0.01% | 2365 |
|
|
2023
Q1 | $403K | Buy |
58,935
+15,125
| +35% | +$103K | ﹤0.01% | 2029 |
|
|
2022
Q4 | $347K | Buy |
43,810
+28
| +0.1% | +$222 | ﹤0.01% | 2078 |
|
|
2022
Q3 | $421K | Buy |
43,782
+23,530
| +116% | +$226K | ﹤0.01% | 1971 |
|
|
2022
Q2 | $146K | Buy |
+20,252
| New | +$146K | ﹤0.01% | 2235 |
|
|
2021
Q3 | – | Sell |
-102,449
| Closed | -$1.42M | – | 1744 |
|
|
2021
Q2 | $1.42M | Sell |
102,449
-14,193
| -12% | -$196K | ﹤0.01% | 1157 |
|
|
2021
Q1 | $1.7M | Sell |
116,642
-5,198
| -4% | -$75.9K | 0.01% | 985 |
|
|
2020
Q4 | $2.12M | Sell |
121,840
-198
| -0.2% | -$3.44K | 0.01% | 913 |
|
|
2020
Q3 | $2.28M | Buy |
122,038
+40,924
| +50% | +$764K | 0.01% | 756 |
|
|
2020
Q2 | $1.45M | Sell |
81,114
-37,556
| -32% | -$671K | 0.01% | 793 |
|
|
2020
Q1 | $1.93M | Sell |
118,670
-50,181
| -30% | -$814K | 0.02% | 656 |
|
|
2019
Q4 | $3.04M | Sell |
168,851
-55,461
| -25% | -$999K | 0.02% | 625 |
|
|
2019
Q3 | $4.54M | Sell |
224,312
-77,363
| -26% | -$1.57M | 0.03% | 489 |
|
|
2019
Q2 | $6.67M | Buy |
301,675
+194
| +0.1% | +$4.29K | 0.05% | 397 |
|
|
2019
Q1 | $4.11M | Buy |
301,481
+10,794
| +4% | +$147K | 0.03% | 459 |
|
|
2018
Q4 | $2.63M | Sell |
290,687
-84,985
| -23% | -$769K | 0.02% | 531 |
|
|
2018
Q3 | $6.2M | Buy |
375,672
+46,528
| +14% | +$768K | 0.05% | 368 |
|
|
2018
Q2 | $4.61M | Buy |
+329,144
| New | +$4.61M | 0.06% | 190 |
|